October 22, 2014 11:16 PM ET

Biotechnology

Company Overview of Avid Radiopharmaceuticals, Inc.

Company Overview

Avid Radiopharmaceuticals, Inc. engages in the development of molecular imaging agents for the medical management of chronic human diseases. The company was founded in 2004 and is based in Philadelphia, Pennsylvania. As of December 20, 2010, Avid Radiopharmaceuticals, Inc. operates as a subsidiary of Eli Lilly and Company.

3711 Market Street

7th Floor

Philadelphia, PA 19104

United States

Founded in 2004

Phone:

215-298-0700

Fax:

413-826-0416

Key Executives for Avid Radiopharmaceuticals, Inc.

Chief Scientific Advisor and Chairman of the Scientific Advisory Board
Chief Medical Officer
Vice President of Clinical Development
Vice President of Chemical Development and Manufacturing
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Sierra Sciences, LLC United States
Allozyne, Inc. United States
Etubics Corporation United States
ProteoGenex, Inc. United States
Stratatech Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Avid Radiopharmaceuticals, Inc., please visit www.avidrp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.